Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3050 of 3546 entries
View as:

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT02058368 Org: User:
Start: 02/10/14 End: 03/03/17 Due: 03/03/18

Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation

Phase: N/A Priority: Normal
NCT ID: NCT01431911 Org: User:
Start: 10/31/10 End: 03/31/11 Due: 03/31/12

Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule

Phase: N/A Priority: Normal
NCT ID: NCT00307034 Org: User:
Start: 01/01/06 End: 01/25/07 Due: 01/25/08

Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium

Phase: N/A Priority: Normal
NCT ID: NCT02201238 Org: User:
Start: 10/01/14 End: 11/21/14 Due: 11/21/15

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Phase: N/A Priority: Normal
NCT ID: NCT00136604 Org: User:
Start: 01/22/06 End: 04/23/06 Due: 04/23/07

Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)

Phase: N/A Priority: Normal
NCT ID: NCT00688207 Org: User:
Start: 04/30/08 End: 09/30/08 Due: 09/30/09

To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02262689 Org: User:
Start: 01/08/15 End: 04/24/15 Due: 04/24/16

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM

Phase: N/A Priority: Normal
NCT ID: NCT06655818 Org: User:
Start: 03/09/21 End: 02/14/24 Due: 02/14/25

Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00140738 Org: User:
Start: 03/10/05 End: 09/29/09 Due: 09/29/10

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00866528 Org: User:
Start: 07/09/09 End: 10/25/12 Due: 10/25/13

A Study to Compare Two Paracetamol Formulations.

Phase: N/A Priority: Normal
NCT ID: NCT01592227 Org: User:
Start: 12/31/09 End: 12/31/09 Due: 12/31/10

Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

Phase: N/A Priority: Normal
NCT ID: NCT01597700 Org: User:
Start: 01/13/12 End: 01/30/12 Due: 01/30/13

Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years

Phase: N/A Priority: Normal
NCT ID: NCT02757963 Org: User:
Start: 05/12/16 End: 02/27/17 Due: 02/27/18

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00046111 Org: User:
Start: 09/30/01 End: 04/30/04 Due: 04/30/05

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00514904 Org: User:
Start: 09/18/07 End: 01/06/09 Due: 01/06/10

A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.

Phase: N/A Priority: Normal
NCT ID: NCT01266941 Org: User:
Start: 10/18/10 End: 07/15/11 Due: 07/15/12

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

Phase: N/A Priority: Normal
NCT ID: NCT00972725 Org: User:
Start: 12/01/09 End: 10/04/10 Due: 10/04/11

Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01622231 Org: User:
Start: 06/30/12 End: 11/30/12 Due: 11/30/13

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT01627561 Org: User:
Start: 10/15/12 End: 10/06/16 Due: 10/06/17

Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03702036 Org: User:
Start: - End: - Due: -

To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03543137 Org: User:
Start: 06/18/18 End: 11/12/18 Due: 11/12/19

A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00411814 Org: User:
Start: 11/30/06 End: 02/29/08 Due: 02/28/09

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00947115 Org: User:
Start: 09/22/09 End: 02/03/15 Due: 02/03/16

A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00979771 Org: User:
Start: 02/01/10 End: 04/28/11 Due: 04/28/12

Daprodustat Hepatic Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT03223337 Org: User:
Start: 07/24/17 End: 08/20/18 Due: 08/20/19